| 000 | 01577 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515114237.0 | ||
| 264 | 0 | _c20080410 | |
| 008 | 200804s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLelong-Rebel, Isabelle | |
| 245 | 0 | 0 |
_aEffect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a55-68 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xmetabolism |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aCell Growth Processes _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Resistance, Multiple |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMucin-2 |
| 650 | 0 | 4 |
_aMucins _xbiosynthesis |
| 650 | 0 | 4 |
_aOxygen _xadministration & dosage |
| 650 | 0 | 4 |
_aSucrase-Isomaltase Complex _xmetabolism |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 700 | 1 | _aBrisson, Christine | |
| 700 | 1 | _aFabre, Michel | |
| 700 | 1 | _aBergerat, Jean-Pierre | |
| 700 | 1 | _aRebel, Gérard | |
| 773 | 0 |
_tAnticancer research _gvol. 28 _gno. 1A _gp. 55-68 |
|
| 999 |
_c17883282 _d17883282 |
||